Literature DB >> 15650770

Role of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapy.

Anne Angelillo-Scherrer1, Laurent Burnier, Nathalie Flores, Pierre Savi, Maria DeMol, Paul Schaeffer, Jean-Marc Herbert, Greg Lemke, Stephen P Goff, Glenn K Matsushima, H Shelton Earp, Christian Vesin, Marc F Hoylaerts, Stéphane Plaisance, Désiré Collen, Edward M Conway, Bernhard Wehrle-Haller, Peter Carmeliet.   

Abstract

Mechanisms regulating thrombus stabilization remain largely unknown. Here, we report that loss of any 1 of the Gas6 receptors (Gas6-Rs), i.e., Tyro3, Axl, or Mer, or delivery of a soluble extracellular domain of Axl that traps Gas6 protects mice against life-threatening thrombosis. Loss of a Gas6-R does not prevent initial platelet aggregation but impairs subsequent stabilization of platelet aggregates, at least in part by reducing "outside-in" signaling and platelet granule secretion. Gas6, through its receptors, activates PI3K and Akt and stimulates tyrosine phosphorylation of the beta3 integrin, thereby amplifying outside-in signaling via alphaIIbbeta3. Blocking the Gas6-R-alphaIIbbeta3 integrin cross-talk might be a novel approach to the reduction of thrombosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650770      PMCID: PMC544035          DOI: 10.1172/JCI22079

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family.

Authors:  Q Lu; G Lemke
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

Review 2.  The integrin alpha IIb/beta 3 in human platelet signal transduction.

Authors:  B Payrastre; K Missy; C Trumel; S Bodin; M Plantavid; H Chap
Journal:  Biochem Pharmacol       Date:  2000-10-15       Impact factor: 5.858

3.  Tyro-3 family receptors are essential regulators of mammalian spermatogenesis.

Authors:  Q Lu; M Gore; Q Zhang; T Camenisch; S Boast; F Casagranda; C Lai; M K Skinner; R Klein; G K Matsushima; H S Earp; S P Goff; G Lemke
Journal:  Nature       Date:  1999-04-22       Impact factor: 49.962

4.  Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development.

Authors:  T Kawasaki; M Dewerchin; H R Lijnen; I Vreys; J Vermylen; M F Hoylaerts
Journal:  Circ Res       Date:  2001-02-02       Impact factor: 17.367

5.  Integrin cytoplasmic tyrosine motif is required for outside-in alphaIIbbeta3 signalling and platelet function.

Authors:  D A Law; F R DeGuzman; P Heiser; K Ministri-Madrid; N Killeen; D R Phillips
Journal:  Nature       Date:  1999-10-21       Impact factor: 49.962

6.  Variable protection of beta 3-integrin--deficient mice from thrombosis initiated by different mechanisms.

Authors:  S S Smyth; E D Reis; H Väänänen; W Zhang; B S Coller
Journal:  Blood       Date:  2001-08-15       Impact factor: 22.113

7.  Vascular release of plasminogen activator inhibitor-1 impairs fibrinolysis during acute arterial thrombosis in mice.

Authors:  T Kawasaki; M Dewerchin; H R Lijnen; J Vermylen; M F Hoylaerts
Journal:  Blood       Date:  2000-07-01       Impact factor: 22.113

8.  Gas6 anti-apoptotic signaling requires NF-kappa B activation.

Authors:  F Demarchi; R Verardo; B Varnum; C Brancolini; C Schneider
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

9.  Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice.

Authors:  C Léon; B Hechler; M Freund; A Eckly; C Vial; P Ohlmann; A Dierich; M LeMeur; J P Cazenave; C Gachet
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

10.  Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.

Authors:  A Angelillo-Scherrer; P de Frutos; C Aparicio; E Melis; P Savi; F Lupu; J Arnout; M Dewerchin; M Hoylaerts; J Herbert; D Collen; B Dahlbäck; P Carmeliet
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

View more
  79 in total

1.  Elevated plasma gas6 levels are associated with venous thromboembolic disease.

Authors:  Mark D Blostein; Isabelle Rajotte; Deepa P Rao; Christina A Holcroft; Susan R Kahn
Journal:  J Thromb Thrombolysis       Date:  2011-10       Impact factor: 2.300

Review 2.  Macrophage-tumor crosstalk: role of TAMR tyrosine kinase receptors and of their ligands.

Authors:  Thomas Schmidt; Isabel Ben-Batalla; Alexander Schultze; Sonja Loges
Journal:  Cell Mol Life Sci       Date:  2011-11-11       Impact factor: 9.261

3.  Inhibition of Mer and Axl receptor tyrosine kinases in astrocytoma cells leads to increased apoptosis and improved chemosensitivity.

Authors:  Amy K Keating; Grace K Kim; Ashley E Jones; Andrew M Donson; Kathryn Ware; Jean M Mulcahy; Dana B Salzberg; Nicholas K Foreman; Xiayuan Liang; Andrew Thorburn; Douglas K Graham
Journal:  Mol Cancer Ther       Date:  2010-04-27       Impact factor: 6.261

Review 4.  The role of TAM family receptors and ligands in the nervous system: From development to pathobiology.

Authors:  Bridget Shafit-Zagardo; Ross C Gruber; Juwen C DuBois
Journal:  Pharmacol Ther       Date:  2018-03-04       Impact factor: 12.310

5.  Structural basis for Gas6-Axl signalling.

Authors:  Takako Sasaki; Pjotr G Knyazev; Naomi J Clout; Yuri Cheburkin; Walter Göhring; Axel Ullrich; Rupert Timpl; Erhard Hohenester
Journal:  EMBO J       Date:  2005-12-15       Impact factor: 11.598

6.  Eph kinases and ephrins support thrombus growth and stability by regulating integrin outside-in signaling in platelets.

Authors:  Nicolas Prévost; Donna S Woulfe; Hong Jiang; Timothy J Stalker; Patrizia Marchese; Zaverio M Ruggeri; Lawrence F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-01       Impact factor: 11.205

Review 7.  Minding the gaps to promote thrombus growth and stability.

Authors:  Lawrence F Brass; Li Zhu; Timothy J Stalker
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

8.  Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.

Authors:  Weihe Zhang; Andrew L McIver; Michael A Stashko; Deborah DeRyckere; Brian R Branchford; Debra Hunter; Dmitri Kireev; Michael J Miley; Jacqueline Norris-Drouin; Wendy M Stewart; Minjung Lee; Susan Sather; Yingqiu Zhou; Jorge A Di Paola; Mischa Machius; William P Janzen; H Shelton Earp; Douglas K Graham; Stephen V Frye; Xiaodong Wang
Journal:  J Med Chem       Date:  2013-11-20       Impact factor: 7.446

Review 9.  Systems biology of platelet-vessel wall interactions.

Authors:  Yolande Chen; Seth Joel Corey; Oleg V Kim; Mark S Alber
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

10.  Localization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons.

Authors:  A L Prieto; S O'Dell; B Varnum; C Lai
Journal:  Neuroscience       Date:  2007-09-26       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.